{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:13:42Z","timestamp":1788437622063,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.dsx.2024.103074","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T06:24:20Z","timestamp":1721111060000},"page":"103074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological survey"],"prefix":"10.1016","volume":"18","author":[{"given":"Jingyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoguan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriette GC.","family":"Van Spall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1184-1791","authenticated-orcid":false,"given":"Guowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10397","key":"10.1016\/j.dsx.2024.103074_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dsx.2024.103074_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ejhf.2034","article-title":"Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review","volume":"23","author":"Whitelaw","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.dsx.2024.103074_bib3","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2021971","article-title":"Racial disproportionality in covid clinical trials","volume":"383","author":"Chastain","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.dsx.2024.103074_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.2017.025288","article-title":"Representation of minorities and women in oncology clinical trials: review of the past 14 years","volume":"14","author":"Duma","year":"2018","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.dsx.2024.103074_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37640","article-title":"Assessment of the inclusion of racial\/ethnic minority, female, and older individuals in vaccine clinical trials","volume":"4","author":"Flores","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.dsx.2024.103074_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","article-title":"Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review","volume":"297","author":"Van Spall","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.dsx.2024.103074_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.122.061450","article-title":"Creation of the American heart association journals' equity, diversity, and inclusion editorial board: the next step to achieving the 2024 impact goal","volume":"146","author":"Lewis","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2024.103074_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ahj.2019.05.011","article-title":"Hospital participation in clinical trials for patients with acute myocardial infarction: results from the National Cardiovascular Data Registry","volume":"214","author":"Fanaroff","year":"2019","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.dsx.2024.103074_bib9","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.2337\/dc22-0261","article-title":"Enrollment of black, indigenous, and other people of color in multicountry randomized controlled trials of diabetes conducted in North America and Europe","volume":"45","author":"Zhang","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.dsx.2024.103074_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015594","article-title":"Ten-year trends in enrollment of women and minorities in pivotal trials supporting recent US Food and drug administration approval of novel cardiometabolic drugs","volume":"9","author":"Khan","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.dsx.2024.103074_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2640","article-title":"Participation of black US residents in clinical trials of 24 cardiovascular drugs granted FDA approval, 2006-2020","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"18","key":"10.1016\/j.dsx.2024.103074_bib12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs","volume":"71","author":"Scott","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.dsx.2024.103074_bib13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2018.2559","article-title":"Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review","volume":"3","author":"Tahhan","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.dsx.2024.103074_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006605","article-title":"Representation of women authors in international heart failure guidelines and contemporary clinical trials","volume":"13","author":"Reza","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.dsx.2024.103074_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008685","article-title":"Factors associated with racial and ethnic diversity among heart failure trial participants: a systematic bibliometric review","volume":"15","author":"Wei","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"1\/2","key":"10.1016\/j.dsx.2024.103074_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2307\/2333011","article-title":"A distribution-free k-sample test against ordered alternatives","volume":"41","author":"Jonckheere","year":"1954","journal-title":"Biometrika"},{"key":"10.1016\/j.dsx.2024.103074_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1003162622169","article-title":"Local polynomial regression: optimal kernels and asymptotic minimax efficiency","volume":"49","author":"Fan","year":"1997","journal-title":"Ann Inst Stat Math"},{"issue":"4","key":"10.1016\/j.dsx.2024.103074_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3928\/01484834-20140325-04","article-title":"Understanding Poisson regression","volume":"53","author":"Hayat","year":"2014","journal-title":"J Nurs Educ"},{"issue":"1","key":"10.1016\/j.dsx.2024.103074_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3588","article-title":"Racial and ethnic subgroup reporting in diabetes randomized controlled trials published from 2000 to 2020: a survey","volume":"39","author":"Li","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2024.103074_bib21","article-title":"SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline","volume":"373","author":"Li","year":"2021","journal-title":"Bmj"},{"issue":"7","key":"10.1016\/j.dsx.2024.103074_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102804","article-title":"Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus","volume":"17","author":"Zhang","year":"2023","journal-title":"Diabetes Metabol Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2024.103074_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/dom.14540","article-title":"Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment","volume":"24","author":"Tang","year":"2022","journal-title":"Diabetes Obes Metabol"},{"issue":"5","key":"10.1016\/j.dsx.2024.103074_bib24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/endrev\/bnab007","article-title":"Conducting real-world evidence studies on the clinical outcomes of diabetes treatments","volume":"42","author":"Schneeweiss","year":"2021","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.dsx.2024.103074_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/EDE.0000000000001230","article-title":"Reweighting oranges to apples: transported RE-LY trial versus nonexperimental effect estimates of anticoagulation in atrial fibrillation","volume":"31","author":"Webster-Clark","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.dsx.2024.103074_bib30","first-page":"39406","article-title":"Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice","volume":"58","year":"1993","journal-title":"Fed Regist"},{"issue":"5","key":"10.1016\/j.dsx.2024.103074_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2105\/AJPH.2011.300621","article-title":"The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma","volume":"102","author":"Sabin","year":"2012","journal-title":"Am J Publ Health"},{"issue":"87","key":"10.1016\/j.dsx.2024.103074_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.socscimed.2013.03.016","article-title":"Racial attitudes, physician-patient talk time ratio, and adherence in racially discordant medical interactions","volume":"1982","author":"Hagiwara","year":"2013","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.dsx.2024.103074_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-4505-13-8","article-title":"Barriers and opportunities for enhancing patient recruitment and retention in clinical research: findings from an interview study in an NHS academic health science centre","volume":"13","author":"Adams","year":"2015","journal-title":"Health Res Pol Syst"},{"issue":"9","key":"10.1016\/j.dsx.2024.103074_bib34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.167.9.905","article-title":"Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials","volume":"167","author":"Ding","year":"2007","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.dsx.2024.103074_bib35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM199902253400806","article-title":"The effect of race and sex on physicians' recommendations for cardiac catheterization","volume":"340","author":"Schulman","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.dsx.2024.103074_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJMsa032214","article-title":"Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002","volume":"353","author":"Vaccarino","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.dsx.2024.103074_bib37","first-page":"135","article-title":"Representation of women in randomized clinical trials of cardiovascular disease prevention","volume":"3","author":"Melloni","year":"2010","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"6","key":"10.1016\/j.dsx.2024.103074_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13749","article-title":"Analysis of female enrollment and participant sex by burden of disease in US clinical trials between 2000 and 2020","volume":"4","author":"Steinberg","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.dsx.2024.103074_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamacardio.2020.0167","article-title":"Improving racial and ethnic minority representation in cardiovascular disease trials to advance health equity","volume":"5","author":"Ifidon","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.dsx.2024.103074_bib40","series-title":"Improving representation in clinical trials and research: building research equity for women and underrepresented groups","article-title":"Engineering, and medicine; policy and global affairs; committee on women in science, engineering, and medicine; committee on improving the representation of women and underrepresented minorities in clinical trials and research","year":"2022"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124001358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:20:42Z","timestamp":1788434442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124001358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1871402124001358"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103074","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological survey","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.103074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103074"}}